FDA Inspection 1201351 — Melanie Palm, MD
The FDA completed an inspection of Melanie Palm, MD on February 23, 2023 in Solana Beach, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 23, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Solana Beach, CA (United States)
Additional Details
Clinical Investigator (CI)